Literature DB >> 24316631

GSK plows ahead with EMA malaria vaccine submission.

Aaron Bouchie.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24316631     DOI: 10.1038/nbt1213-1066a

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

1.  GlaxoSmithKline malaria vaccine phase 3 trial heralded.

Authors:  Simon Franz
Journal:  Nat Biotechnol       Date:  2011-12-08       Impact factor: 54.908

2.  Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine.

Authors:  Robert A Seder; Lee-Jah Chang; Mary E Enama; Kathryn L Zephir; Uzma N Sarwar; Ingelise J Gordon; LaSonji A Holman; Eric R James; Peter F Billingsley; Anusha Gunasekera; Adam Richman; Sumana Chakravarty; Anita Manoj; Soundarapandian Velmurugan; MingLin Li; Adam J Ruben; Tao Li; Abraham G Eappen; Richard E Stafford; Sarah H Plummer; Cynthia S Hendel; Laura Novik; Pamela J M Costner; Floreliz H Mendoza; Jamie G Saunders; Martha C Nason; Jason H Richardson; Jittawadee Murphy; Silas A Davidson; Thomas L Richie; Martha Sedegah; Awalludin Sutamihardja; Gary A Fahle; Kirsten E Lyke; Matthew B Laurens; Mario Roederer; Kavita Tewari; Judith E Epstein; B Kim Lee Sim; Julie E Ledgerwood; Barney S Graham; Stephen L Hoffman
Journal:  Science       Date:  2013-08-08       Impact factor: 47.728

  2 in total
  1 in total

Review 1.  Vaccines for the 21st century.

Authors:  Isabel Delany; Rino Rappuoli; Ennio De Gregorio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.